As your cell and gene therapies move from early-phase clinical trials to commercialization, your supply chain complexity—and risk—increases. Anticipating setbacks and planning for their solution requires a specialized and collaborative approach with your supply chain partner.

During this on-demand webinar, you’ll hear from industry experts who offer insights into developing a commercial supply chain for emerging autologous and allogeneic therapies.

Get insights into:

  • Proven supply chain strategies that have supported the successful commercial launch of cell and gene therapies
  • Keys to forming and maintaining successful collaborations in cell therapy starting material procurement and management
  • The importance of leveraging partners that have historical expertise and offer comprehensive support across the commercial supply chain
  • Decisions made during clinical development to help anticipate challenges at each phase of advancement and streamline commercialization


Chris McClain, MBA
Senior Vice President, Sales & Business Development
Be The Match BioTherapies®

Aileen Baquiran
Vice President, Global Supply Chain and Business Operations
Orchard Therapeutics

Access on-demand webinar